Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04050618
Other study ID # EX-MKTG-103
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 9, 2019
Est. completion date November 8, 2019

Study information

Verified date September 2020
Source Coopervision, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To evaluate the comparative clinical performance of the fanfilcon A silicone hydrogel lens used in daily wear and to compare this with competitive hydrogel lens products.


Description:

This 8-week, subject-masked, bilateral, two-part, cross-over evaluation will compare the clinical performance of fanfilcon A silicone hydrogel contact lens and competitive hydrogel contact lenses when worn daily. Lenses will be replaced either on a 2-weekly or 4-weekly basis, depending on control lens group.


Recruitment information / eligibility

Status Completed
Enrollment 114
Est. completion date November 8, 2019
Est. primary completion date September 24, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Be a currently adapted soft contact lens wearer (>1 month of lens wear). - Be at least 18 years of age. - Refractive astigmatism <1.00D in both eyes. - Have clear corneas and be free of any anterior segment disorders. - Be correctable through spherocylindrical refraction to 20/25 or better in each eye. - Contact lens sphere requirement between -1.00D and -6.00D (inclusive). - Require visual correction in both eyes (monovision allowed, no monofit). - Have normal eyes with no evidence of abnormality or disease. For the purposes of this study a normal eye is defined as one having: 1. No amblyopia 2. No strabismus 3. No evidence of lid abnormality or infection 4. No conjunctival abnormality or infection that would contraindicate contact lens wear 5. No clinically significant slit lamp findings (i.e. corneal staining, stromal edema, staining, scarring, vascularization, infiltrates or abnormal opacities) 6. No other active ocular disease. - Own a mobile phone and be able to respond to SMS survey during the period 8am-8pm. - Willing to comply with the wear and study visit schedule. Exclusion Criteria: - Using CooperVision Avaira Vitality, J&J Acuvue 2 or CooperVision Biomedics 55. - Require toric or multifocal contact lenses. - Previously shown a sensitivity to any of the study solution components. - Any systemic or ocular disease or allergies affecting ocular health. - Using systemic or topical medications that will in the investigator's opinion affect ocular physiology or lens performance. - Clinically significant (>Grade 3) corneal staining, corneal stromal edema, corneal vascularization, tarsal abnormalities, bulbar hyperemia, limbal hyperemia, or any other abnormality of the cornea that would contraindicate contact lens wear. - Any corneal infiltrates or any corneal scarring or neovascularization within the central 5mm of the cornea. - Keratoconus or other corneal irregularity. - Aphakia or amblyopia. - Have undergone corneal refractive surgery or any anterior segment surgery. - Abnormal lacrimal secretions. - Has diabetes. - Known/reported infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease (e.g., HIV). - History of chronic eye disease (e.g. glaucoma). - Pregnant or lactating or planning a pregnancy at the time of enrolment. - Participation in any concurrent clinical trial or in last 30 days.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
fanfilcon A test lens
Silicone hydrogel contact lens
ocufilcon D control lens
hydrogel contact lens
etafilcon A control lens
hydrogel contact lens

Locations

Country Name City State
United States Omega Vision Center PA (DBA Sabal Eye Care) Longwood Florida
United States Office of William J. Bogus, O.D. Salt Lake City Utah
United States Golden Vision Sarasota Florida
United States Frazier Vision, Inc Tyler Texas
United States Sacco Eye Group Vestal New York
United States Golden Optometric Group Whittier California

Sponsors (1)

Lead Sponsor Collaborator
Coopervision, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Subjective Overall Comfort Rating Subjective overall comfort rating was assessed on a 0-10 subjective scale, 0=extremely uncomfortable, 10=can't feel lenses Two weeks
Primary Subjective Overall Comfort Rating Subjective overall comfort rating was assessed on a 0-10 subjective scale, 0=extremely uncomfortable, 10=can't feel lenses Four weeks
Secondary Average Wearing Time Average wearing time - measured by time of day using 24-hour clock, to the nearest 10 minutes Two weeks
Secondary Average Wearing Time Average wearing time - measured by time of day using 24-hour clock, to the nearest 10 minutes Four weeks
Secondary Average Comfortable Wearing Time Average comfortable wearing time was assessed by time of day when first aware of lenses using 24-hour clock, to the nearest 10 minutes. Two weeks
Secondary Average Comfortable Wearing Time Average comfortable wearing time was assessed by time of day when first aware of lenses using 24-hour clock, to the nearest 10 minutes. Four weeks
Secondary Lens Centration Lens centration will be recorded in the scale of 0 to 2 (0=centered - optimal, 1 = decentered slightly, 2 = substantially decentered (>0.5mm)). Baseline (after 15 minutes)
Secondary Lens Centration Lens centration will be recorded in the scale of 0 to 2 (0=centered - optimal, 1 = decentered slightly, 2 = substantially decentered (>0.5mm)). Two weeks
Secondary Lens Centration Lens centration will be recorded in the scale of 0 to 2 (0=centered - optimal, 1 = decentered slightly, 2 = substantially decentered (>0.5mm)). Four weeks
Secondary Corneal Coverage Corneal coverage (yes=full corneal coverage all times / no=incomplete corneal coverage) Baseline (after 15 minutes of lens dispense)
Secondary Corneal Coverage Corneal coverage (yes=full corneal coverage all times / no=incomplete corneal coverage) Two weeks
Secondary Corneal Coverage Corneal coverage (yes=full corneal coverage all times / no=incomplete corneal coverage) Four weeks
Secondary Post-Blink Movement Post-blink movement measured by scale 0-4 (0=insufficient, 1=minimal, unacceptable movement, 2=optimal movement, 3=moderate, but acceptable movement, 4=excessive, unacceptable movement) Baseline (after 15 minutes of lens dispense)
Secondary Post-Blink Movement Post-blink movement measured by scale 0-4 (0=insufficient, 1=minimal, unacceptable movement, 2=optimal movement, 3=moderate, but acceptable movement, 4=excessive, unacceptable movement) Two weeks
Secondary Post-Blink Movement Post-blink movement measured by scale 0-4 (0=insufficient, 1=minimal, unacceptable movement, 2=optimal movement, 3=moderate, but acceptable movement, 4=excessive, unacceptable movement) Four weeks
Secondary Lens Tightness - Push-up Test Lens tightness - push-up test 0-100% continuous scale (100%=movement, 50%=optimum, 0%=Falls from cornea without lid support) Baseline (after 15 minutes of lens dispense)
Secondary Lens Tightness - Push-up Test Lens tightness - push-up test 0-100% continuous scale (100%=movement, 50%=optimum, 0%=Falls from cornea without lid support) Two weeks
Secondary Lens Tightness - Push-up Test Lens tightness - push-up test 0-100% continuous scale (100%=movement, 50%=optimum, 0%=Falls from cornea without lid support) Four weeks
Secondary Overall Lens Fit Acceptance Overall lens fit acceptance - Graded on a scale of 0-4 (0=should not be worn, 1=borderline but not acceptable, 2=minimal acceptable, 3=not perfect but OK to dispense, 4=perfect) Baseline (after 15 minutes of lens dispense)
Secondary Overall Lens Fit Acceptance Overall lens fit acceptance - Graded on a scale of 0-4 (0=should not be worn, 1=borderline but not acceptable, 2=minimal acceptable, 3=not perfect but OK to dispense, 4=perfect) Two weeks
Secondary Overall Lens Fit Acceptance Overall lens fit acceptance - Graded on a scale of 0-4 (0=should not be worn, 1=borderline but not acceptable, 2=minimal acceptable, 3=not perfect but OK to dispense, 4=perfect) Four weeks
Secondary Rating of Lens Surface Wettability Lens surface wettability rated on the appearance on the lens surface (0-4 scale, 0=Very poor: immediately displaying non-wetting areas on lens surface, 4=Excellent: appearance of a healthy cornea with very long drying time). Baseline (after 15 minutes of lens dispense)
Secondary Rating of Lens Surface Wettability Lens surface wettability rated on the appearance on the lens surface (0-4 scale, 0=Very poor: immediately displaying non-wetting areas on lens surface, 4=Excellent: appearance of a healthy cornea with very long drying time). Two weeks
Secondary Rating of Lens Surface Wettability Lens surface wettability rated on the appearance on the lens surface (0-4 scale, 0=Very poor: immediately displaying non-wetting areas on lens surface, 4=Excellent: appearance of a healthy cornea with very long drying time). Four weeks
Secondary Presence of Film Deposits Presence of film deposits on front surface of the lens graded 0-4 (0=No film, 1=Slight film visible only under magnification, 2=Moderate film only under magnification, 3=Moderate film visible to the naked eye, 4=heavy film visible to the naked eye). Two weeks
Secondary Presence of Film Deposits Presence of film deposits on front surface of the lens graded 0-4 (0=No film, 1=Slight film visible only under magnification, 2=Moderate film only under magnification, 3=Moderate film visible to the naked eye, 4=heavy film visible to the naked eye). Four weeks
Secondary Number of White Spot Deposits Number of white spot deposits assessed using slit lamp with white light, low medium magnification Two weeks
Secondary Number of White Spot Deposits Number of white spot deposits assessed using slit lamp with white light, low medium magnification Four weeks
Secondary Primary Gaze Lag Primary gaze lag measured by scale 0-4 (0=insufficient, 1=minimal, unacceptable movement, 2=optimal movement, 3=moderate, but acceptable movement, 4=excessive, unacceptable movement) Baseline (after 15 minutes of lens dispense)
Secondary Primary Gaze Lag Primary gaze lag measured by scale 0-4 (0=insufficient, 1=minimal, unacceptable movement, 2=optimal movement, 3=moderate, but acceptable movement, 4=excessive, unacceptable movement) Two weeks
Secondary Primary Gaze Lag Primary gaze lag measured by scale 0-4 (0=insufficient, 1=minimal, unacceptable movement, 2=optimal movement, 3=moderate, but acceptable movement, 4=excessive, unacceptable movement) Four weeks
Secondary Comfort Throughout the Day Comfort throughout the day was assessed on a scale of 0-10 (0=extremely uncomfortable, 10=cannot feel the lenses) using text message responses Day 3 - 8:00am
Secondary Comfort Throughout the Day Comfort throughout the day was assessed on a scale of 0-10 (0=extremely uncomfortable, 10=cannot feel the lenses) using text message responses Day 3 - 12:00pm
Secondary Comfort Throughout the Day Comfort throughout the day was assessed on a scale of 0-10 (0=extremely uncomfortable, 10=cannot feel the lenses) using text message responses Day 3 - 4:00pm
Secondary Comfort Throughout the Day Comfort throughout the day was assessed on a scale of 0-10 (0=extremely uncomfortable, 10=cannot feel the lenses) using text message responses Day 3 - 8:00pm
Secondary Comfort Throughout the Day Comfort throughout the day was assessed on a scale of 0-10 (0=extremely uncomfortable, 10=cannot feel the lenses) using text message responses Day 7 - 8:00am
Secondary Comfort Throughout the Day Comfort throughout the day was assessed on a scale of 0-10 (0=extremely uncomfortable, 10=cannot feel the lenses) using text message responses Day 7 - 12:00pm
Secondary Comfort Throughout the Day Comfort throughout the day was assessed on a scale of 0-10 (0=extremely uncomfortable, 10=cannot feel the lenses) using text message responses Day 7 - 4:00pm
Secondary Comfort Throughout the Day Comfort throughout the day was assessed on a scale of 0-10 (0=extremely uncomfortable, 10=cannot feel the lenses) using text message responses Day 7 - 8:00pm
Secondary Comfort Throughout the Day Comfort throughout the day was assessed on a scale of 0-10 (0=extremely uncomfortable, 10=cannot feel the lenses) using text message responses Day 12 - 8:00am
Secondary Comfort Throughout the Day Comfort throughout the day was assessed on a scale of 0-10 (0=extremely uncomfortable, 10=cannot feel the lenses) using text message responses Day 12 - 12:00pm
Secondary Comfort Throughout the Day Comfort throughout the day was assessed on a scale of 0-10 (0=extremely uncomfortable, 10=cannot feel the lenses) using text message responses Day 12 - 4:00pm
Secondary Comfort Throughout the Day Comfort throughout the day was assessed on a scale of 0-10 (0=extremely uncomfortable, 10=cannot feel the lenses) using text message responses Day 12 - 8:00pm
Secondary Comfort Throughout the Day Comfort throughout the day was assessed on a scale of 0-10 (0=extremely uncomfortable, 10=cannot feel the lenses) using text message responses Day 26 - 8:00am
Secondary Comfort Throughout the Day Comfort throughout the day was assessed on a scale of 0-10 (0=extremely uncomfortable, 10=cannot feel the lenses) using text message responses Day 26 - 12:00pm
Secondary Comfort Throughout the Day Comfort throughout the day was assessed on a scale of 0-10 (0=extremely uncomfortable, 10=cannot feel the lenses) using text message responses Day 26 - 4:00pm
Secondary Comfort Throughout the Day Comfort throughout the day was assessed on a scale of 0-10 (0=extremely uncomfortable, 10=cannot feel the lenses) using text message responses Day 26 - 8:00pm
See also
  Status Clinical Trial Phase
Recruiting NCT04923841 - Myopia Control Using Bright Light Therapy, Myopic Defocus and Atropine N/A
Active, not recruiting NCT04080128 - Examination of Myopia Progression and Soft Bifocal Contact Lens Myopia Control N/A
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Completed NCT04604405 - Effects of 650nm Low Energy Light on Human Retina and Choroid Microcirculation N/A
Recruiting NCT05594719 - The Effect of Sun-like Spectrum With Different Spectrum Composition on Retinal Blood Flow N/A
Completed NCT05594732 - The Effects of Different Outdoor Light Exposure Modes on Retinal Blood Flow N/A
Completed NCT04492397 - Comparing The Performance Of Two Different Daily Disposable Lenses (MIKI) N/A
Completed NCT04536571 - Vision Stability and Preference for Soft Toric vs. Soft Spherical Contact Lenses N/A
Completed NCT06046209 - Comparing a Monthly Replacement Lens Versus a Daily Disposable Lens N/A
Recruiting NCT06344572 - Pivotal Study of SAT-001 in Treatment of Pediatric Patient With Myopia Phase 3
Recruiting NCT05611294 - Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction N/A
Completed NCT05656885 - Clinical Evaluation of Two Frequent Replacement Soft Spherical Contact Lenses N/A
Active, not recruiting NCT05534022 - Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression. N/A
Completed NCT03934788 - the Clinical Performance of the Oxysoft Daily Disposable Silicone Hydrogel Soft Contact Lens N/A
Completed NCT03701516 - Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2 N/A
Completed NCT05538754 - Post-Market Evaluation of the EVO ICL N/A
Completed NCT03139201 - Clinical Performance of the OxyAqua Daily Disposable Silicone Hydrogel Soft Contact Lens N/A
Completed NCT02555722 - Evaluation of the CooperVision, Inc. Fanfilcon A and Enfilcon A Daily Wear Contact Lenses When Used for Frequent Replacement for up to One (1) Month of Daily Wear N/A
Not yet recruiting NCT06009458 - Acuity 200™ (Fluoroxyfocon A) Orthokeratology Contact Lens for Overnight Wear N/A
Recruiting NCT05548478 - Corneal Endothelial Cell Injury Induced by Mitomycin-C N/A